Eli Lilly Plans To End Clinical Trial Contract
Dan McGowan, InsideINdianaBusiness.com Indianapolis-based Eli Lilly and Co. is planning to end a clinical trial contract with the University of California, San Diego. The collaboration involves solanezumab, the company’s prospective Alzheimer’s disease treatment. The pharmaceutical maker says the decision was triggered by a recent series of staff departures, … Read More